Purpose: To describe the follow-up of patients with orbital Wegener granulomatosis after antithymocyte globulin treatment.
Methods: Patients with ocular/orbital Wegener granulomatosis refractory to standard treatment were selected for immunotherapy with rabbit antithymocyte globulin intravenously. The specific ocular/orbital symptoms were monitored in patients with a vision-threatening form of Wegener granulomatosis or a life-threatening form with ocular symptoms.
Results: One patient had a complete remission, two patients had remissions but still needed additional treatment, and one patient remained refractory.
Conclusions: In selected patients, antithymocyte globulin immunotherapy may present an alternative when vision or life is threatened by orbital Wegener granulomatosis.